Ashlee Eichenlaub, APRN

NPI: 1376083857
Total Payments
$3,732
2024 Payments
$578.84
Companies
27
Transactions
242
Medicare Patients
2,051
Medicare Billing
$93,340

Payment Breakdown by Category

Food & Beverage$3,732 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,732 242 100.0%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $971.54 80 $0 (2024)
ABBVIE INC. $700.05 50 $0 (2024)
Janssen Biotech, Inc. $275.21 17 $0 (2023)
Regeneron Healthcare Solutions, Inc. $258.69 11 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $238.59 13 $0 (2024)
Merck Sharp & Dohme LLC $192.11 11 $0 (2023)
IRONWOOD PHARMACEUTICALS, INC $149.32 9 $0 (2024)
Gilead Sciences, Inc. $134.00 6 $0 (2024)
GENZYME CORPORATION $130.71 6 $0 (2024)
PFIZER INC. $92.77 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $578.84 31 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($114.99)
2023 $1,787 110 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($369.15)
2022 $466.58 30 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($167.35)
2021 $900.13 71 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($320.05)

All Payment Transactions

242 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
11/26/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $27.92 General
Category: LIVER DISEASE
11/14/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $14.50 General
Category: VIROLOGY
10/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $34.79 General
Category: INTERNAL MEDICINE
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.90 General
Category: Gastroenterology
09/23/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $14.67 General
Category: LIVER DISEASE
09/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.66 General
Category: Gastroenterology
07/31/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $13.80 General
Category: GASTROENTEROLOGY
07/30/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $16.76 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
06/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $16.11 General
Category: Gastroenterology
05/15/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.14 General
Category: Gastroenterology
04/22/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $18.39 General
Category: Gastroenterology
04/02/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $16.01 General
Category: THERAPY FOR CSID
03/21/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.49 General
Category: Gastroenterology
03/12/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $17.50 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
03/06/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $28.43 General
Category: INFLAMMATION AND IMMUNOLOGY
03/05/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $13.79 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
02/28/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $20.20 General
Category: Immunology
02/21/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $13.96 General
Category: GASTROENTEROLOGY
02/20/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $19.28 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
02/20/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $16.57 General
Category: VIROLOGY
02/12/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $19.47 General
Category: INFLAMMATION AND IMMUNOLOGY
02/07/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.53 General
Category: GASTROENTEROLOGY
01/31/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $27.72 General
Category: Immunology
01/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $17.30 General
Category: Gastroenterology
01/29/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $21.63 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 382 445 $63,362 $22,178
2022 4 343 417 $54,538 $16,827
2021 6 702 901 $90,130 $35,467
2020 7 624 768 $59,398 $18,868
Total Patients
2,051
Total Services
2,531
Medicare Billing
$93,340
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 104 130 $18,980 $7,961 41.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 162 191 $18,874 $7,024 37.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 30 $7,800 $2,092 26.8%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 39 39 $5,290 $1,755 33.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 23 27 $5,346 $1,229 23.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 16 16 $3,936 $1,091 27.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 12 12 $3,136 $1,026 32.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 231 287 $32,490 $10,107 31.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 36 47 $8,230 $2,816 34.2%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 34 34 $5,660 $1,685 29.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 28 33 $6,014 $1,472 24.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 14 16 $2,144 $746.28 34.8%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 338 471 $53,530 $20,392 38.1%
99203 New patient outpatient visit, total time 30-44 minutes Facility 2021 56 56 $8,368 $3,600 43.0%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 158 195 $7,410 $3,228 43.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 45 54 $7,236 $2,543 35.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 39 51 $5,522 $2,042 37.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 24 27 $4,398 $1,855 42.2%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2021 42 47 $3,666 $1,805 49.2%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2020 296 403 $15,314 $6,795 44.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 167 195 $23,738 $5,773 24.3%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 49 49 $7,894 $2,158 27.3%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2020 29 29 $2,262 $966.00 42.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 22 29 $3,142 $859.23 27.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 11 11 $2,062 $649.44 31.5%

About Ashlee Eichenlaub, APRN

Ashlee Eichenlaub, APRN is a Family healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1376083857.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashlee Eichenlaub, APRN has received a total of $3,732 in payments from pharmaceutical and medical device companies, with $578.84 received in 2024. These payments were reported across 242 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,732).

As a Medicare-enrolled provider, Eichenlaub has provided services to 2,051 Medicare beneficiaries, totaling 2,531 services with total Medicare billing of $93,340. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Other Specialties Family
  • Location Ashland, KY
  • Active Since 03/02/2017
  • Last Updated 03/03/2022
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1376083857

Products in Payments

  • XIFAXAN (Drug) $664.50
  • DUPIXENT (Biological) $389.40
  • TRULANCE (Drug) $307.04
  • ENTYVIO (Biological) $226.35
  • MAVYRET (Drug) $217.28
  • STELARA (Biological) $197.89
  • DIFICID (Drug) $192.11
  • Linzess (Drug) $149.32
  • LINZESS (Drug) $143.21
  • RINVOQ (Biological) $93.25
  • CREON (Drug) $82.73
  • XELJANZ (Drug) $81.50
  • REBYOTA (Biological) $79.90
  • REMICADE (Biological) $77.32
  • Wegovy (Drug) $68.96
  • ZENPEP (Drug) $68.69
  • VIBERZI (Drug) $58.35
  • SKYRIZI (Biological) $55.94
  • HUMIRA (Biological) $49.29
  • RESMETIROM (Drug) $42.59

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Ashland